BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37339766)

  • 41. Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections.
    Veletzky L; Eberhardt KA; Hergeth J; Stelzl DR; Zoleko Manego R; Kreuzmair R; Burger G; Mischlinger J; McCall MBB; Mombo-Ngoma G; Adegnika AA; Agnandji ST; Matsiegui PB; Lell B; Kremsner P; Mordmüller B; Tappe D; Ramharter M
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012054. PubMed ID: 38484012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.
    Akue JP; Nkoghe D; Padilla C; Moussavou G; Moukana H; Mbou RA; Ollomo B; Leroy EM
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1329. PubMed ID: 22022623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
    Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
    BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
    Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excess mortality associated with loiasis: a retrospective population-based cohort study.
    Chesnais CB; Takougang I; Paguélé M; Pion SD; Boussinesq M
    Lancet Infect Dis; 2017 Jan; 17(1):108-116. PubMed ID: 27777031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa.
    Ngwewondo A; Wang M; Manfo FPT; Samje M; Ganin's JN; Ndi E; Andersen RJ; Cho-Ngwa F
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006565. PubMed ID: 29897908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
    Abegunde AT; Ahuja RM; Okafor NJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon.
    Wanji S; Tendongfor N; Nji T; Esum M; Che JN; Nkwescheu A; Alassa F; Kamnang G; Enyong PA; Taylor MJ; Hoerauf A; Taylor DW
    Parasit Vectors; 2009 Aug; 2(1):39. PubMed ID: 19712455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon.
    Touré FS; Egwang TG; Millet P; Bain O; Georges AJ; Wahl G
    Trop Med Int Health; 1998 Apr; 3(4):313-7. PubMed ID: 9623933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
    Lenk EJ; Moungui HC; Boussinesq M; Kamgno J; Nana-Djeunga HC; Fitzpatrick C; Peultier AMM; Klion AD; Fletcher DA; Nutman TB; Pion SD; Niamsi-Emalio Y; Redekop WK; Severens JL; Stolk WA
    Clin Infect Dis; 2020 Apr; 70(8):1628-1635. PubMed ID: 31165855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onchocerca volvulus infection in Tihama region - west of Yemen: Continuing transmission in ivermectin-targeted endemic foci and unveiled endemicity in districts with previously unknown status.
    Mahdy MAK; Abdul-Ghani R; Abdulrahman TAA; Al-Eryani SMA; Al-Mekhlafi AM; Alhaidari SAA; Azazy AA
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006329. PubMed ID: 29505580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
    Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
    Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a
    Brito M; Paulo R; Van-Dunem P; Martins A; Unnasch TR; Novak RJ; Jacob B; Stanton MC; Molyneux DH; Kelly-Hope LA
    Parasite Epidemiol Control; 2017 Aug; 2(3):71-84. PubMed ID: 29774284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple filarial species microfilaraemia: a comparative study of areas with endemic and sporadic onchocerciasis.
    Uttah E; Ibeh DC
    J Vector Borne Dis; 2011 Dec; 48(4):197-204. PubMed ID: 22297280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
    Mbah GE; Ayiseh RB; Cho-Ngwa F
    BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis.
    Martin-Prevel Y; Cosnefroy JY; Tshipamba P; Ngari P; Chodakewitz JA; Pinder M
    Am J Trop Med Hyg; 1993 Feb; 48(2):186-92. PubMed ID: 8447521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of Loa loa-specific DNA in blood from occult-infected individuals.
    Touré FS; Bain O; Nerrienet E; Millet P; Wahl G; Toure Y; Doumbo O; Nicolas L; Georges AJ; McReynolds LA; Egwang TG
    Exp Parasitol; 1997 Jul; 86(3):163-70. PubMed ID: 9225766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative treatment strategies to accelerate the elimination of onchocerciasis.
    Boussinesq M; Fobi G; Kuesel AC
    Int Health; 2018 Mar; 10(suppl_1):i40-i48. PubMed ID: 29471342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
    Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M
    Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.